Celldex Therapeutics Inc
F:TCE2
Celldex Therapeutics Inc
F:TCE2
Price:
36.65
EUR
3.04%
Market Cap:
€2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
C
|
Caixabank SA
XMUN:48CA
|
ES |
Shareholder Yield
Current shareholder yield for 
TCE2 is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
TCE2 Price
Celldex Therapeutics Inc
Celldex Therapeutics Inc
Annual Price Range
36.65
52w Low
17
52w High
36.65
Price Metrics
| Average Annual Return | -7.51% |
| Standard Deviation of Annual Returns | 22.18% |
| Max Drawdown | -73% |
Shares Statistics
| Market Capitalization | 3.4B EUR |
| Shares Outstanding | 65 910 000 |
| Percentage of Shares Shorted |
N/A
|
TCE2 Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
TCE2's latest stock split occurred on Feb 11, 2019
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, TCE2 traded at 0.488 per share. Afterward, the share price was about 4.19.
The adjusted shares began trading on Feb 11, 2019. This was the only stock split in TCE2's history.
Pre-Split Price
7.32
0.488
Post-Split Price
4.19
Before
After
